Today: 17 April 2026
Air Products and Chemicals stock jumps on earnings beat; APD faces Monday test
1 February 2026
1 min read

Air Products and Chemicals stock jumps on earnings beat; APD faces Monday test

New York, Feb 1, 2026, 07:31 EST — The market has closed.

  • Shares ended up 6.4% at $272.50, following quarterly results and guidance that met expectations
  • Adjusted EPS for Q1 came in at $3.16, beating estimates; revenue climbed to $3.1 billion
  • Attention turns to helium demand, discipline on major projects, and Monday’s factory data release

Shares of Air Products and Chemicals jumped roughly 6.4% to $272.50 on Friday. The industrial gases company topped quarterly earnings estimates and stuck to its full-year guidance.

This is crucial as the company works to regain trust following a tough period marked by significant charges from project cancellations and a reset in investor spending outlook. A straightforward beat and reaffirmation often face swift scrutiny. Monday’s reopening will reveal whether Friday’s rally was driven by genuine confidence or just relief.

Air Products operates in a segment of the chemicals market where contracts usually include clauses passing energy and fuel costs onto customers—a straightforward “you pay more when our energy bill rises” setup. Investors are focused on whether trimming prices and costs can sustain earnings growth as volume gains stall.

Air Products posted a profit of $678.2 million, or $3.04 per share, for the quarter ended Dec. 31, up from $617.4 million a year ago. Adjusted earnings, which exclude certain items, came in at $3.16 per share, beating analysts’ $3.04 forecast. Revenue rose 5.8% to $3.1 billion.

In its latest filing, the company reported a 14% jump in GAAP operating income, reaching $735 million. First-quarter sales were up 6%, boosted by higher energy pass-through and currency gains that offset steady volumes. It flagged “helium headwinds” and weaker helium demand but kept its fiscal 2026 adjusted EPS forecast steady at $12.85 to $13.15 per share. Capital spending is projected around $4.0 billion. SEC

Chief Executive Officer Eduardo Menezes highlighted “strong results from the base business,” emphasizing once more the focus on optimizing large projects and maintaining capital discipline.

The filing also highlighted a few points investors keep asking about: ongoing talks with Yara International on low-emission ammonia projects in the U.S. and Saudi Arabia, plus supply deals with NASA worth over $140 million to deliver liquid hydrogen.

Air Products surged noticeably amid a generally weak market on Friday. Industrial gas rival Linde saw a slight gain, but the broader market finished in the red, per MarketWatch data.

Risks remain two-sided. Weak helium demand or volume cuts by customers could make the “pass-through” revenue boost seem stronger than the actual demand. Plus, updates on big projects — permits, partners, costs, timing — have the power to shift sentiment quickly.

The January ISM manufacturing PMI arrives promptly at 10:00 a.m. EST Monday. This key indicator on new orders and production frequently sets the tone for industrial stocks at the month’s start.

Stock Market Today

  • Hims & Hers Stock Rises as FDA Considers Loosening Peptide Restrictions
    April 17, 2026, 10:37 AM EDT. Hims & Hers (HIMS) shares climbed 6% in early trading Thursday, extending gains after a 13% surge Wednesday. The rally follows FDA plans to reassess the classification of seven peptides currently restricted for compounding pharmacies, signaling potential regulatory easing. Health Secretary Robert F. Kennedy Jr. announced the move to shift these peptides from a banned Category 2 status to review by the Pharmacy Compounding Advisory Committee, which could broaden regulated access and reduce black market demand. Market optimism ties to Hims & Hers' recent acquisition of a peptide manufacturing plant aimed at treatments like weight loss and muscle recovery. Despite the midday jump, HIMS remains down 23% year-to-date amid ongoing regulatory risks and previous patent disputes with drugmaker Novo Nordisk.

Latest article

XRP Price Today: XRP Climbs to $1.44 as ETF Inflows, Risk-On Mood Lift Ripple-Linked Token

XRP Price Today: XRP Climbs to $1.44 as ETF Inflows, Risk-On Mood Lift Ripple-Linked Token

17 April 2026
XRP climbed to about $1.44 in early New York trading Friday, up 2.5% in 24 hours with turnover over $4 billion, outpacing bitcoin and ether. U.S.-listed spot XRP ETFs saw $17 million in net inflows on April 15, the highest since February. Ripple announced a partnership with Kyobo Life Insurance for Korea’s first tokenised government bond settlement project. XRP remains about 60% below its all-time high.
Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

17 April 2026
Gold hovered near $4,784 an ounce Friday, set for a fourth weekly gain despite easing 0.1% by 0815 GMT. A 10-day Lebanon-Israel ceasefire and possible U.S.-Iran talks kept investors watching for diplomatic progress. Indian gold imports stalled as banks await new government authorization, leaving over 5 tons stuck at customs. Spot silver rose 0.7% to $78.97, platinum held steady, and palladium slipped 0.1%.
Phoenix Asia Holdings (PHOE) stock jumps nearly 1,000% — what to watch before Monday’s Nasdaq open
Previous Story

Phoenix Asia Holdings (PHOE) stock jumps nearly 1,000% — what to watch before Monday’s Nasdaq open

ArcBest stock price jumped after a brutal earnings swing — what to watch next week
Next Story

ArcBest stock price jumped after a brutal earnings swing — what to watch next week

Go toTop